<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Rev Inst Med Trop Sao Paulo</journal-id>
      <journal-id journal-id-type="iso-abbrev">Rev. Inst. Med. Trop. Sao Paulo</journal-id>
      <journal-id journal-id-type="publisher-id">rimtsp</journal-id>
      <journal-title-group>
        <journal-title>Revista do Instituto de Medicina Tropical de S&#xE3;o Paulo</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0036-4665</issn>
      <issn pub-type="epub">1678-9946</issn>
      <publisher>
        <publisher-name>Instituto de Medicina Tropical</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">27828626</article-id>
      <article-id pub-id-type="pmc">5096639</article-id>
      <article-id pub-id-type="doi">10.1590/S1678-9946201658085</article-id>
      <article-id pub-id-type="other">00601</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letter to the Editor</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>OCULAR COMPLICATIONS CAUSED BY <bold><italic>Cryptococcus gattii</italic></bold> AFLP4/VGI MENINGITIS IN AN IMMUNOCOMPETENT HOST</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>CHEN</surname>
            <given-names>Chang-Hua</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>(1)</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>WANG</surname>
            <given-names>Shao-Hung</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
<sup>(2)</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>CHEN</surname>
            <given-names>Wei Liang</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
<sup>(3)</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>WANG</surname>
            <given-names>Wang-Fu</given-names>
          </name>
          <xref ref-type="aff" rid="aff4">
<sup>(4)</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>CHEN</surname>
            <given-names>San-Ni</given-names>
          </name>
          <xref ref-type="aff" rid="aff5">
<sup>(5)</sup>
</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>(1)</label> Changhua Christian Hospital, Division of Infectious Disease, Departament of Internal, Changhua, Taiwan.</aff>
      <aff id="aff2"><label>(2)</label> National Chiayi University, Department of Microbiology, Immunology and Biopharmaceuticals, Chiayi City, Taiwan.</aff>
      <aff id="aff3"><label>(3)</label> Changhua Christian Hospital, Department of Medical Imaging, Changhua, Taiwan.</aff>
      <aff id="aff4"><label>(4)</label> Changhua Christian Hospital, Department of Neurology, Changhua, Taiwan.</aff>
      <aff id="aff5"><label>(5)</label> Changhua Christian Hospital, Department of Ophthalmology, Changhua, Taiwan</aff>
      <author-notes>
        <corresp id="c1">Correspondence to: Chang-Hua Chen, Division of Infectious Disease, Department of Internal Medicine, Changhua Christian Hospital, Changhua, Taiwan. E-mail: <email>76590@cch.org.tw</email></corresp>
        <fn fn-type="COI-statement" id="fn1">
          <p><bold>COMPETING INTERESTS:</bold> The authors declare that they have no competing interests.</p>
        </fn>
        <fn fn-type="con" id="fn4">
          <p><bold>AUTHORS CONTRIBUTION:</bold> CHC and WFW conceived and designed this study. CHC and WFW analyzed the data, wrote the paper, prepared figures and/or tables. CHC, WFW, SNC, and WLC served this patient. SHW performed the experiments. All authors reviewed drafts of the paper. </p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub">
        <day>03</day>
        <month>11</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2016</year>
      </pub-date>
      <volume>58</volume>
      <elocation-id>85</elocation-id>
      <history>
        <date date-type="received">
          <day>15</day>
          <month>6</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>15</day>
          <month>9</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License</license-p>
        </license>
      </permissions>
      <counts>
        <fig-count count="1"/>
        <table-count count="0"/>
        <equation-count count="0"/>
        <ref-count count="6"/>
        <page-count count="1"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <p>Changhua, June 15, 2016</p>
    <p>Dear Editor</p>
    <p>The <italic>Cryptococcus gattii</italic> complex has been recognized as an endemic pathogen since the 1990s and has caused multiple outbreaks since then<xref rid="B1" ref-type="bibr">
<sup>1</sup>
</xref>. Cryptococcal meningitis (CM) is a globally occurring invasive mycosis associated with significant morbidity and mortality<xref rid="B2" ref-type="bibr">
<sup>2</sup>
</xref>
<sup>,</sup>
<xref rid="B3" ref-type="bibr">
<sup>3</sup>
</xref>, including papilledema and visual loss<xref rid="B1" ref-type="bibr">
<sup>1</sup>
</xref>
<sup>,</sup>
<xref rid="B3" ref-type="bibr">
<sup>3</sup>
</xref>. We present a case of CM caused by <italic>C. gattii sensu stricto</italic> (AFLP4/VGI) that was complicated by visual loss under the continuation of antifungal therapy (AFT).</p>
    <p>A 45-year-old woman complained of neck stiffness and headaches for two weeks. She was admitted to a community hospital. Her opening intracranial pressure (ICP) was 230 mmH<sub>2</sub>O. A cerebrospinal fluid (CSF) study revealed the following values: protein, 53 mg/dL (reference range, 10-45 mg/dL); glucose, 62 mg/dL (45-75 mg/dL); white blood cells (WBCs), 84/mL (&lt;5/mL); lymphocytes, 79% (63-99%); and neutrophils, 17% (0-2%). The <italic>Cryptococcus</italic> antigen titer in both CSF and serum were positive, at 1:8 and 1:64, respectively. With the impression of a diagnosis of CM, the patient received intravenous amphotericin B (AmB; 0.7 mg/kg/day) with flucytosine (5-FC; 100 mg/kg/day) for two weeks, followed by intravenous AmB (1 mg/kg/day) for another two weeks. Then, a consolidation therapeutic regimen with oral fluconazole (FLC; 450 mg/day orally) was administered for the following three months. She was rehospitalized because of seizures, unfavorable CSF data, and progression of the brain MRI finding. Her opening ICP was 180 mmH<sub>2</sub>O. A follow-up CSF study revealed the following values: protein, 140 mg/dL; glucose, 68 mg/dL; WBCs, 468/mL; lymphocytes, 69/mL; and neutrophils, 16/mL. The cryptococcal antigen titer in CSF was 1:128, and staining the CSF with India ink reveled positivity for the pathogen. Hence, CM was still present. We prescribed a combination therapy for reinduction, but she noticed floaters and blurred vision (ou) since the first day of the second admission. Her eye findings were as follows: visual acuity, no light perception (ou), and fungus with: papilledema, subhyaloid hemorrhage, and retinal hemorrhage. Her fundus color photograph and follow-up MRI scan are presented in <xref ref-type="fig" rid="f1">Figure 1</xref>. The cryptococcal isolate 44-6 was identified as <italic>C. gattii sensu stricto</italic> according to the findings of the culture using canavanine-glycine-bromothymol blue medium. Molecular identification by sequencing the <italic>URA</italic>5 gene revealed that the isolate was genotype AFLP4/VGI, representing the recently described species <italic>C. gattii sensu stricto</italic>
<xref rid="B4" ref-type="bibr">
<sup>4</sup>
</xref>. She received consolidated oral FLC (450 mg/day) at home in the following years. No new neurological sequelae were found after a follow-up period of 3 years, except for visual loss.</p>
    <p>
<fig id="f1" orientation="portrait" position="float"><label>Fig. 1</label><caption><title>Timeline of the <italic>C. gattii</italic> AFLP4/VGI infection, a serial brain magnetic resonance image, and serial fundus color photographs. The magnetic resonance image (A, B, October) and 1-month follow-up magnetic resonance image (C, D, November) were analyzed. The axial, short tau inversion recovery (STIR) image (A, C) and axial, fat-suppressed, post-contrast, T1-weighted image (B, D) demonstrate a faint but increased signal in both the non-expanded optic nerves (A, arrow). Enhancement (B) in the follow-up STIR image (C, arrow) shows progression of the high-signal change and mild atrophy of both the optic nerves. The lesser enhancement (D) is consistent with progression of visual loss. The initial fundus color photograph (E, October) and 1-month follow-up fundus color photograph (F, November) show retinal hemorrhage.</title></caption><graphic xlink:href="0036-4665-rimtsp-58-00085-gf1"/></fig>
</p>
    <p>To our knowledge, this is the first case report to describe ocular complications of CM caused by <italic>C. gattii</italic> AFLP4/VGI under continuation of AFT in Taiwan. In general, <italic>C. gattii</italic> AFLP4/VGI tends to produce larger and more numerous cryptococcomas in the central nervous system<xref rid="B1" ref-type="bibr">
<sup>1</sup>
</xref>. Seaton <italic>et al</italic>. suggested that the high rate of visual loss in immunocompetent patients with <italic>C. gattii</italic> AFLP4/VGI infections may reflect immune-mediated optic nerve dysfunction in <italic>C. gattii</italic> meningitis caused by either compression due to arachnoid adhesions or edema and inflammatory cell-mediated damage<xref rid="B5" ref-type="bibr">
<sup>5</sup>
</xref>. The optic nerve lesion can be due to direct destruction by this pathogen<xref rid="B5" ref-type="bibr">
<sup>5</sup>
</xref> or indirectly caused by increased intracranial pressure<xref rid="B6" ref-type="bibr">
<sup>6</sup>
</xref>. Our case was treated in accordance with the recommendation in the guidelines<xref rid="B3" ref-type="bibr">
<sup>3</sup>
</xref>, but her eye condition continued to deteriorate, most likely due to optic nerve damage (<xref ref-type="fig" rid="f1">Fig. 1</xref>). Use of corticosteroids could be recommended for immunocompetent patients with severe <italic>C. gattii sensu stricto</italic> (AFLP4/VGI) meningitis.</p>
    <p>CM due to <italic>C. gattii</italic> AFLP4/VGI can cause significant neurological morbidities, including ocular complications. We emphasize that physicians should pay attention to the possible complications of CM in patients, even during active AFT.</p>
  </body>
  <back>
    <ack>
      <title>ACKNOWLEDGEMENTS </title>
      <p>The authors thank the Changhua Christian Hospital for the grant support. All authors thank the assistant of the Clinical Microbiology Laboratory of the Changhua Christian Hospital for their assistance in data collection. Authors thank Miss Yi-Chen Tseng and Miss Chi-Lun Chang, who studied at Department of Microbiology, Immunology and Biopharmaceuticals, National Chiayi University, Chiayi City, for the re-identification of the isolate. This research project would not have been possible without the support of many people. The authors wish to express our gratitude to staffs of Division of Infectious Diseases, Division of Neurosurgery, and Division of Critical Care of Changhua Christian Hospital who were abundantly helpful and offered patient care, invaluable assistance, and support.</p>
    </ack>
    <fn-group>
      <fn fn-type="financial-disclosure" id="fn2">
        <p><bold>ETHICS STATEMENTS:</bold> This study was approved by the Changhua Christian Hospital (CCH) Institutional Review Board [CCH IRB No. 131221] for human subjects</p>
      </fn>
      <fn fn-type="financial-disclosure" id="fn3">
        <p><bold>RESEARCH FUNDING/SUPPORT:</bold> Changhua Christian Hospital (CCH grant 104-CCH-IRP-001, CCH rant 105-CCH-IRP-001) </p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Meyer</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Sorrell</surname>
              <given-names>TC</given-names>
            </name>
          </person-group>
          <article-title>Cryptococcus gattii infections</article-title>
          <source>Clin Microbiol Rev</source>
          <year>2014</year>
          <volume>27</volume>
          <fpage>980</fpage>
          <lpage>1024</lpage>
          <pub-id pub-id-type="pmid">25278580</pub-id>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tseng</surname>
              <given-names>HK</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>CP</given-names>
            </name>
            <name>
              <surname>Ho</surname>
              <given-names>MW</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>PL</given-names>
            </name>
            <name>
              <surname>Lo</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>YH</given-names>
            </name>
          </person-group>
          <article-title>Microbiological, epidemiological, and clinical characteristics and outcomes of patients with cryptococcosis in Taiwan, 1997-2010</article-title>
          <source>PLoS One</source>
          <year>2013</year>
          <volume>8</volume>
          <elocation-id>85</elocation-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Perfect</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Dismukes</surname>
              <given-names>WE</given-names>
            </name>
            <name>
              <surname>Dromer</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Goldman</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Graybill</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Hamill</surname>
              <given-names>RJ</given-names>
            </name>
          </person-group>
          <article-title>Clinical practice guidelines for the management of cryptococcal disease 2010 update by the infectious diseases society of America</article-title>
          <source>Clin Infect Dis</source>
          <year>2010</year>
          <volume>50</volume>
          <fpage>291</fpage>
          <lpage>322</lpage>
          <pub-id pub-id-type="pmid">20047480</pub-id>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hagen</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Khayhan</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Theelen</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Kolecka</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Polacheck</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Sionov</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Recognition of seven species in the Cryptococcus gattii/Cryptococcus neoformans species complex</article-title>
          <source>Fungal Genet Biol</source>
          <year>2015</year>
          <volume>78</volume>
          <fpage>16</fpage>
          <lpage>48</lpage>
          <pub-id pub-id-type="pmid">25721988</pub-id>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Seaton</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Verma</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Naraqi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Wembri</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Warrell</surname>
              <given-names>DA</given-names>
            </name>
          </person-group>
          <article-title>Visual loss in immunocompetent patients with Cryptococcus neoformans var gattii meningitis</article-title>
          <source>Trans R Soc Trop Med Hyg</source>
          <year>1997</year>
          <volume>91</volume>
          <fpage>44</fpage>
          <lpage>49</lpage>
          <pub-id pub-id-type="pmid">9093627</pub-id>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Keltner</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Albert</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Lubow</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Fritsch</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Davey</surname>
              <given-names>LM</given-names>
            </name>
          </person-group>
          <article-title>Optic nerve decompression A clinical pathologic study</article-title>
          <source>Arch Ophthalmol</source>
          <year>1977</year>
          <volume>95</volume>
          <fpage>97</fpage>
          <lpage>104</lpage>
          <pub-id pub-id-type="pmid">189739</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
